1. Home
  2. SWRD vs EOLS Comparison

SWRD vs EOLS Comparison

Compare SWRD & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stewards Inc Common Stock

SWRD

Stewards Inc Common Stock

N/A

Current Price

$3.14

Market Cap

593.4M

Sector

Finance

ML Signal

N/A

Logo Evolus Inc.

EOLS

Evolus Inc.

N/A

Current Price

$7.23

Market Cap

500.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SWRD
EOLS
Founded
1999
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
593.4M
500.0M
IPO Year
2025
2018

Fundamental Metrics

Financial Performance
Metric
SWRD
EOLS
Price
$3.14
$7.23
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
★ $15.00
AVG Volume (30 Days)
238.9K
★ 669.7K
Earning Date
11-17-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1.23
EPS
★ N/A
N/A
Revenue
N/A
★ $297,176,000.00
Revenue This Year
N/A
$12.44
Revenue Next Year
N/A
$17.37
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 11.61
52 Week Low
$1.79
$3.86
52 Week High
$3.57
$9.31

Technical Indicators

Market Signals
Indicator
SWRD
EOLS
Relative Strength Index (RSI) 61.73 44.48
Support Level $2.26 $6.99
Resistance Level $3.57 $7.28
Average True Range (ATR) 0.35 0.35
MACD 0.05 0.02
Stochastic Oscillator 68.16 38.71

Price Performance

Historical Comparison
SWRD
EOLS

About SWRD Stewards Inc Common Stock

Stewards Inc is a diversified financial services company with two complementary business platforms: Private Credit and Real Estate. It provides alternative financing solutions to small and medium-sized businesses (SMBs) underserved by traditional lenders, while also building a portfolio of income-producing and value enhancing real estate assets. The Private Credit Division provides revenue-based funding and related financing products to SMBs nationwide. The Real Estate Division targets strategic investments in residential, mixed-use, and commercial properties designed to generate stable rental income and have the potential for long-term value appreciation. It operates in two segments Financing Solutions, and Real Estate Operations.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: